Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.61M | 10.64M | 8.44M | 7.76M | 6.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.47M | 29.60M | 23.61M | 23.81M | 21.91M |
| Operating Income | -32.47M | -29.60M | -23.61M | -23.81M | -21.91M |
| Income Before Tax | -29.89M | -26.78M | -20.44M | -20.28M | -18.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.89M | -26.78M | -20.44M | -20.28M | -18.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.89M | -26.78M | -20.44M | -20.28M | -18.07M |
| EBIT | -32.47M | -29.60M | -23.61M | -23.81M | -21.91M |
| EBITDA | -32.32M | -29.45M | -23.46M | -23.62M | -21.76M |
| EPS Basic | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 |
| Normalized Basic EPS | -0.41 | -0.37 | -0.29 | -0.29 | -0.26 |
| EPS Diluted | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 |
| Normalized Diluted EPS | -0.41 | -0.37 | -0.29 | -0.29 | -0.26 |
| Average Basic Shares Outstanding | 45.15M | 44.92M | 44.64M | 44.26M | 44.12M |
| Average Diluted Shares Outstanding | 45.15M | 44.92M | 44.64M | 44.26M | 44.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |